Eli Lilly settles Minnesota lawsuit over insulin pricing

Eli Lilly (LLY.N), has settled a lawsuit by Minnesota that accused the three largest insulin makers of deceptively raising the price of the diabetes treatment.
The settlement filed on Wednesday in a New Jersey federal court calls for Lilly to offer Minnesota customers without insurance, who pay for its insulin drugs out of pocket, the option to pay no more than $35 a month for them.